APOBEC3 selects V179I in HIV-1 reverse transcriptase to provide selective advantage for non-nucleoside reverse transcriptase inhibitor-resistant mutants is a research paper published in Frontiers in Virology (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: AI116276
NIAID NIH HHS
Grant: R01 AI116276
National Institutes of Health
Grant: 5R01AI116276-04
Visualization of in vivo HIV-1 vaginal transmission in the presence and absence of PrEP
FWCI
0.29
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals